Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas

被引:102
作者
Nicolae, A. [1 ]
Xi, L. [2 ]
Pittaluga, S. [1 ]
Abdullaev, Z. [3 ]
Pack, S. D. [3 ]
Chen, J. [4 ]
Waldmann, T. A. [4 ]
Jaffe, E. S. [1 ]
Raffeld, M. [2 ]
机构
[1] Ctr Canc Res, Natl Canc Inst, Hematopathol Sect, Bethesda, MD 20892 USA
[2] Ctr Canc Res, Natl Canc Inst, Mol Diagnost Unit, Bethesda, MD USA
[3] Ctr Canc Res, Natl Canc Inst, Pathol Lab, Chromosome Biol Unit, Bethesda, MD USA
[4] Ctr Canc Res, Natl Canc Inst, Lymphoid Malignancies Branch, Bethesda, MD USA
关键词
GRANULAR LYMPHOCYTIC-LEUKEMIA;
D O I
10.1038/leu.2014.200
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2244 / 2248
页数:6
相关论文
共 16 条
[1]   Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling [J].
Bessette, Katherine ;
Lang, Mark L. ;
Fava, Roy A. ;
Grundy, Martin ;
Heinen, Jennifer ;
Horne, Laurie ;
Spolski, Rosanne ;
Al-Shami, Amin ;
Morse, Herbert C., III ;
Leonard, Warren J. ;
Kelly, John A. .
BLOOD, 2008, 111 (01) :344-350
[2]   The role of STAT5 in lymphocyte development and transformation [J].
Heltemes-Harris, Lynn M. ;
Farrar, Michael A. .
CURRENT OPINION IN IMMUNOLOGY, 2012, 24 (02) :146-152
[3]   STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia [J].
Jerez, Andres ;
Clemente, Michael J. ;
Makishima, Hideki ;
Koskela, Hanna ;
LeBlanc, Francis ;
Ng, Kwok Peng ;
Olson, Thomas ;
Przychodzen, Bartlomiej ;
Afable, Manuel ;
Gomez-Segui, Ines ;
Guinta, Kathryn ;
Durkin, Lisa ;
Hsi, Eric D. ;
McGraw, Kathy ;
Zhang, Dan ;
Wlodarski, Marcin W. ;
Porkka, Kimmo ;
Sekeres, Mikkael A. ;
List, Alan ;
Mustjoki, Satu ;
Loughran, Thomas P. ;
Maciejewski, Jaroslaw P. .
BLOOD, 2012, 120 (15) :3048-3057
[4]  
Jonveaux P, 1996, LEUKEMIA, V10, P1453
[5]   Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia [J].
Kiel, Mark J. ;
Velusamy, Thirunavukkarasu ;
Rolland, Delphine ;
Sahasrabuddhe, Anagh A. ;
Chung, Fuzon ;
Bailey, Nathanael G. ;
Schrader, Alexandra ;
Li, Bo ;
Li, Jun Z. ;
Ozel, Ayse B. ;
Betz, Bryan L. ;
Miranda, Roberto N. ;
Medeiros, L. Jeffrey ;
Zhao, Lili ;
Herling, Marco ;
Lim, Megan S. ;
Elenitoba-Johnson, Kojo S. J. .
BLOOD, 2014, 124 (09) :1460-1472
[6]   Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia [J].
Kontro, M. ;
Kuusanmaki, H. ;
Eldfors, S. ;
Burmeister, T. ;
Andersson, E. I. ;
Bruserud, O. ;
Bruemmendorf, T. H. ;
Edgren, H. ;
Gjertsen, B. T. ;
Itala-Remes, M. ;
Lagstrom, S. ;
Lohi, O. ;
Lundan, T. ;
Marti, J. M. L. ;
Majumder, M. M. ;
Parsons, A. ;
Pemovska, T. ;
Rajala, H. ;
Vettenranta, K. ;
Kallioniemi, O. ;
Mustjoki, S. ;
Porkka, K. ;
Heckman, C. A. .
LEUKEMIA, 2014, 28 (08) :1738-1742
[7]   Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia [J].
Koskela, Hanna L. M. ;
Eldfors, Samuli ;
Ellonen, Pekka ;
van Adrichem, Arjan J. ;
Kuusanmaki, Heikki ;
Andersson, Emma I. ;
Lagstrom, Sonja ;
Clemente, Michael J. ;
Olson, Thomas ;
Jalkanen, Sari E. ;
Majumder, Muntasir Mamun ;
Almusa, Henrikki ;
Edgren, Henrik ;
Lepisto, Maija ;
Mattila, Pirkko ;
Guinta, Kathryn ;
Koistinen, Pirjo ;
Kuittinen, Taru ;
Penttinen, Kati ;
Parsons, Alun ;
Knowles, Jonathan ;
Saarela, Janna ;
Wennerberg, Krister ;
Kallioniemi, Olli ;
Porkka, Kimmo ;
Loughran, Thomas P., Jr. ;
Heckman, Caroline A. ;
Maciejewski, Jaroslaw P. ;
Mustjoki, Satu .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (20) :1905-1913
[8]   Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2 [J].
Liu, Suhu ;
Walker, Sarah R. ;
Nelson, Erik A. ;
Cerulli, Robert ;
Xiang, Michael ;
Toniolo, Patricia A. ;
Qi, Jun ;
Stone, Richard M. ;
Wadleigh, Martha ;
Bradner, James E. ;
Frank, David A. .
MOLECULAR CANCER THERAPEUTICS, 2014, 13 (05) :1194-1205
[9]   Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas [J].
Mitchell, TJ ;
John, S .
IMMUNOLOGY, 2005, 114 (03) :301-312
[10]   The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors [J].
Nelson, Erik A. ;
Walker, Sarah R. ;
Weisberg, Ellen ;
Bar-Natan, Michal ;
Barrett, Rosemary ;
Gashin, Laurie B. ;
Terrell, Shariya ;
Klitgaard, Josephine L. ;
Santo, Loredana ;
Addorio, Martha R. ;
Ebert, Benjamin L. ;
Griffin, James D. ;
Frank, David A. .
BLOOD, 2011, 117 (12) :3421-3429